Metropolitan Life Insurance Company (MetLife)’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-18,785
Closed -$354K 2546
2017
Q2
$354K Hold
18,785
﹤0.01% 1955
2017
Q1
$230K Hold
18,785
﹤0.01% 2178
2016
Q4
$299K Hold
18,785
﹤0.01% 2097
2016
Q3
$342K Hold
18,785
﹤0.01% 1971
2016
Q2
$298K Buy
18,785
+593
+3% +$8.84K ﹤0.01% 2052
2016
Q1
$271K Buy
18,192
+7,034
+63% +$110K ﹤0.01% 1971
2015
Q4
$310K Hold
11,158
﹤0.01% 1938
2015
Q3
$199K Hold
11,158
﹤0.01% 2282
2015
Q2
$257K Buy
+11,158
New +$313K ﹤0.01% 2231
2015
Q1
Sell
-6,060
Closed -$202K 2488
2014
Q4
$202K Buy
+6,060
New +$162K ﹤0.01% 2409

Other funds holding OTIC

Metropolitan Life Insurance Company (MetLife)'s OTIC Position: Q3 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Otonomy, Inc. (OTIC) in Q3 2017, closing a stake of 18,785 shares — an estimated $354K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OTIC in Q4 2014 and held it in 10 quarters. The position peaked at $354K in Q2 2017. 84 funds tracked by Wall St. Rank hold OTIC as of Q3 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Otonomy, Inc. position as of Q3 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 18,785 Otonomy, Inc. shares in Q3 2017, an estimated $354K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Otonomy, Inc. in Q4 2014 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Otonomy, Inc. position peaked at $354K in Q2 2017.
  • 84 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2017, filed 14 Nov 2017.